Aziyo Biologics (AZYO) Announces Proposed Public Offering of Common Stock
- Stocks close with gains, led by Dow as investors look for rate insight
- Piper Sandler: Stock rally likely to continue on rising recession risks
- Robinhood (HOOD) rises after saying it plans to launch a credit card for US consumers
- Short sellers target Reddit shares as stock slips
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- Discover Financial Services (DFS) Announces CEO Resignation
- Timken (TKR) Appoints Tarak Mehta as New CEO
- Crude Inventory Increases 3.2 Million Barrels
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Many senior Amazon employees won't get cash raises this year - Fortune
Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock
November 30, 2022 4:08 PM ESTSILVER SPRING, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (Aziyo), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and the patients they treat, today announced that it has commenced an underwritten public offering, subject to market and other conditions, of shares of its common stock. Aziyo also intends to grant the underwriter a 30-day option to purchase additional shares of its common stock equal to 15% of the shares of common stock to be sold in the offering to cover over-allotments, if... More